跳至主要内容
临床试验/NCT04915105
NCT04915105尚未招募不适用

Personal Precise Treatment on Psoriasis and Psoriatic Arthritis and Investigate the Mechanisms of Biological Agents Induced Systemic Lupus Erythematosus

Taichung Veterans General Hospital0 个研究点目标入组 90 人开始时间: 2021年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
90
主要终点
swelling joint count and tenderness joint count

研究概览

简要总结

Part of psoriasis and psoriatic arthritis patients treated with biologics and met primary failure. Therefore, we are going to create a cell based platform to evaluate the treatment effects of different biologics on psoriasis and psoriatic arthritis patients before prescribed by physicians

详细描述

PBMCs isolated from psoriasis and psoriatic arthritis and incubated with Group A streptococcus and different biologics for 24 hours. Cytokines expression in the culture supernatants will be measured and the data can be reference for physician's prescription.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy control without underline disease such as psoriasis and psoriatic arthritis.
  • Psoriasis been diagnosed for over six months and PASI >
  • 3.Psoriatic arthritis been diagnosed for over six months and >1 swallow and tender joints

排除标准

  • 未提供

结局指标

主要结局

swelling joint count and tenderness joint count

时间窗: 2 weeks to 3 months

PSA severity

PASI score

时间窗: 2 weeks to 3 months

Psoriasis skin condition and severity

次要结局

  • DLQI(6 months)
  • CRP(3-6 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验